Our solutions perform the most advanced quantitative analysis of medical imaging (ultrasound, MRI, CT), flow analysis, intracardiac flow analysis and quantification, unique tools for experimental studies on small animals.


Medis Medical Imaging Systems, a portfolio company of Van Herk Ventures, has acquired Advanced Medical Imaging Development, a leading Italian niche player in the cardiac imaging market, ensuring a new phase of expansion.

Sulmona (AQ), 5th May 2020 – Prof. Dr. Giovanni Tonti, Prof. Dr. Eng. Gianni Pedrizzetti and Mr. Emidio Marchese ("Quotaholders"), quotaholders of Advanced Medical Imaging Development S.r.l. ("AMID"), a leading MedTech company engaged in the analysis and accurate quantification of cardiac and cardiovascular imaging, signed an agreement for the sale of 100% of the corporate capital to Medis Medical Imaging Systems B.V. ("Medis"), a portfolio company of Van Herk Ventures, the investment arm of the reputable Dutch long-term investor Mr. Van Herk, which invests in the life sciences sector through direct investments in private and listed companies and in venture capital funds.

AMID, founded in 2000 by a team of interdisciplinary scientists boasting several hundred peer-reviewed studies, is a leading Italian MedTech company engaged in the analysis and accurate quantification of cardiac and cardiovascular imaging via proprietary state-of-the-art software. AMID’s solutions are critical to the diagnosis and treatment of cardiovascular diseases, the #1 cause of mortality in the developed world. AMID offers multi-modal and multi-purpose tracking solutions, optimized for different imaging modalities (Echography, Magnetic Resonance and Computed Tomography), with cardiology and muscle-skeletal applications that work on images produced by medical imaging devices from most manufacturers and are integrated in world leaders’ equipment.

Medis, founded in 1989 after it spun off from Leiden University Medical Center (Netherlands), is a leading medical technology company with focus on the development, validation, worldwide commercialization and support of multi-vendor analytical software solutions in the cardiovascular domain, covering X-ray, IVUS, OCT, MRI as well as MSCT applications. It has a global reach with a subsidiary in the USA and branch offices in Japan and the UK. Since May, 2018 it has been a portfolio company of Van Herk Ventures, which took an equity stake to support the growth in the field of cardiovascular imaging software.

After ca. 20 years of activity, the Quotaholders have completed a succession path through this transaction, ensuring a new expansion phase of AMID, by joining forces with an important Dutch player which will provide its own skills, resources and commercial network. In addition, the Quotaholders will have a key role in the transition phase to guarantee an effective and smooth handover.

Prof. Dr. Giovanni Tonti and Prof. Dr. Eng. Gianni Pedrizzetti, founding partners of AMID, commented on the transaction: “We are happy to have identified in Medis the ideal partner, thanks to its technical skills and commercial network, which can support the future growth of AMID and in the best service for our customers. We are thrilled to start a new expansion phase after 20 years of work in this field focusing on top-notch R&D. Together with the team of Medis we will jointly create a wonderful new future and amaze the world with our innovations. In the next few years, all the three founders of AMID will continue to be personally involved taking care of the technical aspects”.

The Quotaholders were supported by BF & Company, with a team made up of Alessandro Bartolini, Alessandro Zanatta, Lisa Martini and Augusto Amatori, as exclusive financial advisor, in the management of the disposal process, valuation and negotiation matters and coordination of the due diligence process.

DWF (Italy), with a team made up of Michele Cicchetti, Guglielmo Fabbricatore, Marco Annoni, Artemis Tiamkaris, Francesco Provenzano and Alberto Sieli, acted as legal advisor, providing assistance for contractual matters.

Studio Leombruni e Associati, represented by Barbara Antonucci, acted as tax and accounting consultant.


Advanced Medical Imaging Development S.r.l.

AMID, founded in 2000 and based in Sulmona (AQ), Italy, is a leading MedTech company engaged in the analysis and accurate quantification of cardiac and cardiovascular imaging via proprietary state-of-the-art software. It offers multi-modal and multi-purpose tracking solutions, optimized for different imaging modalities (Echo, MRI, CT), which are integrated in equipment produced by world leaders manufacturers in medical imaging. Its solutions are at once state-of-the-art and time tested, having appeared in several hundred peer-reviewed studies and in some cases having become industry standards.

Meet our team

Giovanni Tonti

googlescolar resgate linkedin

Giovanni Tonti CEO / Founder Chief Medical Officer

Giovanni Tonti

CEO / Founder
Chief Medical Officer

googlescolar resgate linkedin linkedin

Giovanni Tonti
1979  Medical Degree ,“Sapienza” University of Rome
1992 Cardiology Specialist
Work experience
  • 1981-1991 Hospital Medical Assistant Internal Medicine and Cardiology
  • 1992 Chief  noninvasive cardiology laboratories
  • 2000 - 2006 Director noninvasive cardiology laboratories Cardiovascular Dept. of Annunziata Hospital, Sulmona
  • 2006 Director, Cardiovascular Dept. Catholic University of Sacred Hearth
  • 2007-2008 Scientific Consultant, Cardiovascular Dept. Catholic University of Sacred Hearth (CB)
  • 2008 -2012  Director of Noninvasive Cardiology , Cardiovascular Dept., AUSL L’Aquila
  • From 01.12 2012 to date Director Cardiolovascular rehabilitation , GEA Medical, European Institute of Rehabilitation, Isernia
  • From 2000 to date Honorary University Fellow, G D’annunzio University of Chieti
  • 2014 Scientific Consultant at CCNVD – (Center for Cardio and Neuro Vascular Researches) Neuromed Institute, "Sapienza" University of Rome

Other work experiences
Cofounder and CEO of AMID S.r.l. (Advanced Medical Imaging Developement)
Cofounder and CEO of LifeString S.r.l. (a company involved in cloud storage and remote processing of medical data)
SIEC (Italian Society of Echocardiography) as member of the Health Technology Assessment Committee
ANMCO (Italian Association of Hospital Cardiologists) from 2011 up today co-chairman of the e-Health committee 
More than 30 scientific paper in leading peer reviewed journals in the cardiology and biomedical engineering field

Gianni Pedrizzetti

googlescolar resgate linkedin

Gianni Pedrizzetti Co-founder Chief Scientific Officer

Gianni Pedrizzetti

Chief Scientific Officer

googlescolar resgate linkedin linkedin

Gianni Pedrizzetti

2006-present: Full Professor of Bioengineering (Professore Ordinario) University of Trieste, Trieste, Italy.
1994        PhD in Hydrodynamics, University of Padova, Italy
1987         Laurea (Master) in Civil Engineering, University of Firenze, Italy
Other Academic Appointments
2012 – 2013  Senior Research Associate, Mount Sinai School of Medicine, NY.
1998 – 2006  Associate Professor, School of Engineering, University of Trieste, Italy.
1998         Senior Research Associate, University of Cambridge, UK.
1992 – 1998  Permanent Research position, University of Firenze, Italy.
1994         Post-Doc, ETSIA, Universidad Politecnica de Madrid, Spain.
1992         Post-Doc, INLS, University of California San Diego, CA.
Reviewer: Assistant EU Commission (FP7-HEALTH). International grants agencies and major journals. Chairman and invited speaker in initiatives and conferences in fluid mechanics or cardiovascular sciences.
Consulting Activities
2006 – present       TomTec GmbH, Munich, Germany.
2004 – present       Siemens Medical Solutions, Ultrasound, Mountain View, CA.
2001 – present       Esaote Spa, Firenze and Genova, Italy.
Recent Grant support
2014 - 2017              Italian Minister of Education and Research (PRIN).
2010 - 2012              America Heart Association, USA (co-PI).
2009 - 2014              EU 7th Framework collaborative project. Grant no. 223615, FP7 – HEALTH – 2007-B. (Industrial Partner Advisor; Coordinated by Katholieke Universiteit Leuven, Belgium).

Emidio Marchese


Emidio Marchese Co-founder Chief Technical Officer and developer

Emidio Marchese

Chief Technical Officer and developer

linkedin linkedin


Since 2000, Chief Technical Officer and developer for AMID (Advanced Medfical Imaging Developments S. R. L., Sulmona, Italy).
Seventeen years as developer and systems responsible in the Italian public health sector.
Five years as IT teacher in a public technical high school. Competences
Advanced Programming Skills
− MC high level and low level languages (commodore/sinclair MC above all)
− Assembler MOS-6502/6510,Intel 8086, motorola 68000 - direct cpu programming.
− MS macro assembler
− MS QBasic
− Borland Turbo Pascal
− Operating systems knowledge: SCO Unix/xenix, IBM Aix, Novell Netware, MS-DOS, Windows.
− Ansi C language (the main progr. language for several years, DOS/windows/Unix apps)
− Zortech/Borland/MS C++ language including STL (the main progr. language until now)
− Low&High levels Database handling and programming.
− Low level (with C/Assembler progr.) data recovery from corrupted storage devices.
− Proprietary format structured data files for original apps., including hypertext (just before the web era).
− direct hardware programming/handling and serial communications for radio broadcasting and commercial shops.
− Low level (proprietary formats) Databases programming for researchers
− Indexing/searching methods (original development)
− statistics packages for clinical researchers
− network distributed apps for clinical purpose
− Dicom encoding/decoding programming (original development)
− 2D/3D graphical programming - OpenGL programming (original developments)
− Matrix handling/calculation and matrix mathematical functions programming (original development)

Other IT Advanced Skills
− DICOM standard for readining/writing medical imaging
o Echography (2D, 3D, Doppler)
o Magnetic Resonance
o Computer Aided Tomography
− Medical Imaging Processing Solutions.
− MatLab, The Matworks MA
− MS Office suite.
Regulatory Tools Expertize:
− RedMine tool for issue management and bug tracking
− Jira bug tracking system
− Tortoise SVN
− Italian, mother language
− English, read/write excellent, oral sufficient.